Form 4 for MRNA Moderna
Accepted 2024-06-04 00:00:00 ET · period of report 2024-05-31 · accession 0001127602-24-017754 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-04 | 2024-06-03 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $140.72 | -339 | 1.47M | -0.0% | -$47.7K |
| D | 2024-06-04 | 2024-05-31 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +651 | 1.47M | +0.0% | — |
| D | 2024-06-04 | 2024-05-31 | MRNA | Hoge Stephen | Pres | M - OptEx | $0.00 | -651 | 4,562 | -12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-03 | S | D | 339 | $140.72 | 1,472,089 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-31 | M | A | 651 | — | 1,472,428 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 3 | Derivative | Restricted Stock Units | 2024-05-31 | M | D | 651 | $0.00 | 4,562 | D | — · — to — | 651 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F4) 25% of the shares subject to this restricted stock unit award vested on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |